This website and third-party tools we use rely on cookies for the best user experience. By selecting "I agree", you agree to cookie usage as described in our Privacy Policy.

SOHO 2026 Annual Meeting

This website and third-party tools we use rely on cookies for the best user experience. By selecting "I agree", you agree to cookie usage as described in our Privacy Policy.

1,267 posters, 47 videos, 13 topics, 4 sessions, 853 authors

Back

SOHO 2026 Annual Meeting

September 9 - 12, 2026 | George R. Brown Convention Center, Houston, Texas

Home Posters by Code Posters by Title Authors Topics Sessions Videos Previous meetings

CT - 278

Overall and Progression-Free Survival in Patients With Epstein-Barr Virus-Driven Posttransplant Lymphoproliferative Disease (EBV+ PTLD) Following Tabelecleucel Treatment: Results From the Phase 3 ALLELE Trial

Preview of Overall and Progression-Free Survival in Patients With Epstein-Barr Virus-Driven Posttransplant Lymphoproliferative Disease (EBV+ PTLD) Following Tabelecleucel Treatment: Results From the Phase 3 ALLELE Trial

View Poster Contact Presenter

Poster Presenter

Christina Hughes

Authors

Christina Hughes

Part of Topic

Cellular Therapy (CT)

Overall and progression-free survival in patients with Epstein-Barr virus–driven post-transplant lymphoproliferative disease (EBV+ PTLD) following tabelecleucel treatment: Results from the phase 3 ALLELE trial

Other ePosters in

Topic

CT - 011Incidence of Polypharmacy Among Emergency Patients at a Tertiary Care Ho...

CT - 012Thrombocytopenia Following CAR-T Therapy: A Systematic Review of Prospec...

CT - 015Assessment of Awareness Regarding Look-Alike, Sound-Alike Medications (L...

CT - 016The Involvement of Pharmacists From Research to Healthcare-An Assessment...

CT - 071Clinical Predictors of Severe Cytokine Release Syndrome in CAR T-Cell Th...

ePosters in

Topics

Myelodysplastic Syndromes (MDS)(71)Myeloproliferative Neoplasms (MPN)(102)T-Cell Lymphoma (TCL)(28)

Previous 1 2 Next